Colon News and Research

RSS

Jennerex, Transgene enter partnership to develop JX-594 product for tumor treatment

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene Euronext, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for the treatment of solid tumors in Europe, the Commonwealth of Independent States (CIS) and the Middle East.

8 Sep 2010

Protagen AG announces € 10.0 Million for second round of finance totaling

Protagen AG, a specialist for in-vitro diagnostics and GMP-compliant protein analysis announced today a second round of finance totalling a volume of € 10.0 Million.

7 Sep 2010

Medicare beneficiaries receive prescription drug cost relief under Affordable Care Act

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced that more than 1 million Medicare beneficiaries have received prescription drug cost relief through the Affordable Care Act.

31 Aug 2010

Reactivation of CDX2 gene may halt progression of colon cancer

The intestines have to work properly if we are to benefit from the food we eat. Digestive juices must be secreted, the food broken down into smaller components and then transported through the gut wall and onwards to muscles and organs. The lining of the gut is coated in epithelial cells, a specialised layer that produces mucous and hormones while keeping dangerous bacteria and toxins at bay. Close contact with pathogenic microbes and toxins means that the epithelial cells may mutate to form cancer.

30 Aug 2010

Eight signs of cancer: Study

Scientists have now identified eight signs of cancer that need immediate attention. These can predict the risk of cancer with such accuracy in certain age groups that patients should be referred to a specialist straight away unless there is a good explanation that is is something else.

30 Aug 2010

U-M researchers explore prevention measures, treatments for C. difficile infection

Clostridium difficile, a wily, familiar bacterium, causes a growing number of serious infections in U.S. hospitals and nursing homes. With a $7.5 million, five-year award from the National Institutes of Health, University of Michigan researchers plan to discover what factors in the microbe and in patients make C. difficile a formidable, costly problem.

27 Aug 2010

Plantain and broccoli fiber help in Crohn’s disease: Study

New research suggests that plant fibers in plantains and broccoli can help prevent relapses of Crohn's disease. This disease is a long term disease of the gut that is characterized by inflammation of the lining of the digestive system, with symptoms including diarrhea and abdominal pain. Crohn's disease affects between 400,000 and 600,000 people in North America. Scientists believe that rise in processed food and decrease in fibers in diet could be a reason for rise of incidence of this disease.

25 Aug 2010

Fox Chase Cancer Center to host Philadelphia Chromosome Symposium

In celebration of a seminal discovery in cancer biology, Fox Chase Cancer Center will host the Philadelphia Chromosome Symposium: Past, Present and Future, on September 28, 2010, from 8 a.m. to 7 p.m. at The Chemical Heritage Foundation, 315 Chestnut Street, Philadelphia. The event marks the 50th anniversary of the discovery of the first genetic abnormality associated with cancer, and the first to lead to a targeted therapy for cancer.

25 Aug 2010

Mayo researchers develop new laboratory cell lines to study anaplastic thyroid cancer

To their deep dismay, researchers at Mayo Clinic discovered several years ago that laboratory samples of anaplastic thyroid cancer (ATC) they were using to help them find new treatments for this lethal disease were probably some other kind of cancer. It quickly became evident that the situation in their lab was common throughout the world. Up to half of the cell lines that were supposed to originate from patients with this rare thyroid cancer were either colon or melanoma cancer.

25 Aug 2010

ACR Image Metrix praises iCAD on FDA clearance of VeraLook Colon CAD software

ACR Image Metrix™, an imaging contract research organization (CRO) with expertise in imaging research design, techniques and data extraction, congratulates their partner, iCAD, Inc., on obtaining U.S. Food and Drug Administration clearance on its VeraLook™, Colon CAD (Computer-Aided Detection) software.

25 Aug 2010

Breast-specific gamma imaging increases radiation-induced cancer risk: Report

Some nuclear-based breast imaging exams may increase a woman's risk of developing radiation-induced cancer, according to a special report appearing online and in the October issue of Radiology. However, the radiation dose and risk from mammography are very low.

24 Aug 2010

Scientists develop nano-sized vehicle to deliver chemotherapy drugs directly into cancer cells

Chemotherapy, while an effective cancer treatment, also brings debilitating side effects such as nausea, liver toxicity and a battered immune system.Now, a new way to deliver this life-saving therapy to cancer patients getting straight to the source of the disease.

24 Aug 2010

Study finds rectal cancer rates are increasing among young individuals

A new analysis has found that while colon cancer rates have remained steady over the past several decades among people under the age of 40, rectal cancer rates are increasing in this population across races and in both sexes.

23 Aug 2010

ASIR can reduce radiation dose associated with abdominal CT scans: Study

A new low-dose abdominal computed tomography (CT) technique called adaptive statistical iterative reconstruction (ASIR) can reduce the radiation dose associated with abdominal CT scans by 23-66 percent, according to a study in the September issue of the American Journal of Roentgenology.

21 Aug 2010

CRC imaging technique identifies early extracolonic lesions of colorectal cancer

Although the medical community has already accepted that colorectal cancer (CRC) screening is cost effective and saves lives, researchers have found that computed tomography colonography (CTC or virtual colonoscopy) not only identifies CRC but also doubles the yield of identifying significant early extracolonic (outside the colon) lesions, resulting in lives saved.

21 Aug 2010

Cancer patients may live longer with palliative and hospice care services: Study

A new study released by the New England Journal of Medicine found that among patients with non-small-cell lung cancer, those who received palliative care lived, on average, almost two months longer than those who received standard care. Researchers also found that the patients receiving palliative care reported a higher quality of life through the final course of their illness.

20 Aug 2010

Stand Up To Cancer prepares for next Team Fundraising Challenge

As part of a new long-term alliance, Stand Up To Cancer is gearing up for its next Team Fundraising Challenge by joining forces with one of television's most popular shows, Survivor on CBS. For the first time ever, Survivor will stand up and issue the "Challenge The Odds" Team Challenge with Stand Up To Cancer Ambassador and winner of Survivor: Africa, Ethan Zohn.

18 Aug 2010

FDA considers dropping Avastin approval, approves five-day emergency contraception pill

The Food and Drug Administration is considering revoking its approval of a last-ditch breast cancer drug over the debate on "medical spending and effectiveness that flared during the battle over health-care reform," The Washington Post reports. "The [FDA] is reviewing the recommendation of influential scientific advisers to revoke authorization of the drug to treat metastatic breast cancer.

17 Aug 2010

Susan G. Komen for the Cure, OCNA urge FDA to allow use of Avastin

Susan G. Komen for the Cure and the Ovarian Cancer National Alliance today urged the U.S. Food and Drug Administration to continue to allow the use of the drug bevacizumab, commonly known as Avastin, for metastatic breast cancer patients, noting that it is effective for some patients and warning of a chilling effect on new drug development if approval is withdrawn.

13 Aug 2010

LCA launches “National Shine a Light on Lung Cancer Vigil” to raise awareness

Today, Lung Cancer Alliance (LCA) announced the launch of the National Shine a Light on Lung Cancer Vigil to honor loved ones, raise awareness and provide hope, compassion and support for all those touched by lung cancer.

12 Aug 2010

Colon News and Research

Jennerex, Transgene enter partnership to develop JX-594 product for tumor treatment

Protagen AG announces € 10.0 Million for second round of finance totaling

Medicare beneficiaries receive prescription drug cost relief under Affordable Care Act

Reactivation of CDX2 gene may halt progression of colon cancer

Eight signs of cancer: Study

U-M researchers explore prevention measures, treatments for C. difficile infection

Plantain and broccoli fiber help in Crohn’s disease: Study

Fox Chase Cancer Center to host Philadelphia Chromosome Symposium

Mayo researchers develop new laboratory cell lines to study anaplastic thyroid cancer

ACR Image Metrix praises iCAD on FDA clearance of VeraLook Colon CAD software

Breast-specific gamma imaging increases radiation-induced cancer risk: Report

Scientists develop nano-sized vehicle to deliver chemotherapy drugs directly into cancer cells

Study finds rectal cancer rates are increasing among young individuals

ASIR can reduce radiation dose associated with abdominal CT scans: Study

CRC imaging technique identifies early extracolonic lesions of colorectal cancer

Cancer patients may live longer with palliative and hospice care services: Study

Stand Up To Cancer prepares for next Team Fundraising Challenge

FDA considers dropping Avastin approval, approves five-day emergency contraception pill

Susan G. Komen for the Cure, OCNA urge FDA to allow use of Avastin

LCA launches “National Shine a Light on Lung Cancer Vigil” to raise awareness

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News